Cargando…

Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease

We evaluated genetics of hyperuricemia and gout, their interaction with kidney function and medication intake in chronic kidney disease (CKD) patients. Genome-wide association studies (GWAS) of urate and gout were performed in 4941 CKD patients in the German Chronic Kidney Disease (GCKD) study. Effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jing, Jiaojiao, Ekici, Arif B., Sitter, Thomas, Eckardt, Kai-Uwe, Schaeffner, Elke, Li, Yong, Kronenberg, Florian, Köttgen, Anna, Schultheiss, Ulla T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123425/ https://www.ncbi.nlm.nih.gov/pubmed/30181573 http://dx.doi.org/10.1038/s41598-018-31282-z

Ejemplares similares

Associations between genetic risk variants for kidney diseases and kidney disease etiology
por: Wunnenburger, Sebastian, et al.
Publicado: (2017)

Spectrum and dosing of urate-lowering drugs in a large cohort of chronic kidney disease patients and their effect on serum urate levels: a cross-sectional analysis from the German Chronic Kidney Disease study
por: Kielstein, Jan T, et al.
Publicado: (2019)

Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease study
por: Schultheiss, Ulla T, et al.
Publicado: (2020)

Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)

Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study
por: Beck, Hanna, et al.
Publicado: (2015)

Correction: Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study
por: Beck, Hanna, et al.
Publicado: (2015)

Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study
por: Schwaiger, Johannes P., et al.
Publicado: (2022)

Effects of multiple genetic loci on the pathogenesis from serum urate to gout
por: Dong, Zheng, et al.
Publicado: (2017)

Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout
por: Tan, Philip K., et al.
Publicado: (2016)

Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
por: Schneider, Markus P., et al.
Publicado: (2018)

Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
por: Schneider, Markus P., et al.
Publicado: (2018)

Urate in fingernail represents the deposition of urate burden in gout patients
por: Chen, Haibing, et al.
Publicado: (2020)

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
por: Uhlig, T., et al.
Publicado: (2022)

Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout
por: Dalbeth, Nicola, et al.
Publicado: (2015)

Replication of Gout/Urate Concentrations GWAS Susceptibility Loci Associated with Gout in a Han Chinese Population
por: Li, Zhiqiang, et al.
Publicado: (2017)

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
por: Wrigley, Rebekah, et al.
Publicado: (2020)

Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
por: Stamp, Lisa K., et al.
Publicado: (2022)

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
por: Pang, Lei, et al.
Publicado: (2023)

Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
por: Khanna, Puja, et al.
Publicado: (2020)

Urate‐lowering therapy for patients with gout on hemodialysis
por: Alkilany, Reem, et al.
Publicado: (2022)

Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis
por: Robinson, Philip C., et al.
Publicado: (2021)

Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
por: Sun, Mengying, et al.
Publicado: (2018)

A Randomized Pilot Study of DASH Patterned Groceries on Serum Urate in Individuals with Gout
por: Juraschek, Stephen P., et al.
Publicado: (2021)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
por: Ran, Zijing, et al.
Publicado: (2021)

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank
por: Narang, Ravi K., et al.
Publicado: (2019)

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
por: Dalbeth, Nicola, et al.
Publicado: (2012)

The relationship between ferritin and urate levels and risk of gout
por: Fatima, Tahzeeb, et al.
Publicado: (2018)

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort
por: Busch, Martin, et al.
Publicado: (2016)

Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
por: Miner, Jeffrey, et al.
Publicado: (2016)

Genetic variants in two pathways influence serum urate levels and gout risk: a systematic pathway analysis
por: Dong, Zheng, et al.
Publicado: (2018)

Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease
por: Mitri, Ghaith, et al.
Publicado: (2016)

Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with Gout
por: Lee, You-Hyun, et al.
Publicado: (2006)

Treatment approaches and adherence to urate-lowering therapy for patients with gout
por: Aung, Thanda, et al.
Publicado: (2017)

Clinical Image: In vivo urate spherulites in a patient with gout
por: Pirker, Ian, et al.
Publicado: (2021)

Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout
por: Hosoya, Tatsuo, et al.
Publicado: (2014)

Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
por: Miner, Jeffrey N., et al.
Publicado: (2016)

Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
por: Flynn, Tanya J, et al.
Publicado: (2015)

Clinical features and recurrent attack in gout patients according to serum urate levels during an acute attack
por: Lee, Jung Sun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jgphd0iadg89dnq1525rnak0au